Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1375-1383

  Sonnenbichler, Johann ^a   Scalera, Fortunato ^a   Sonnenbichler, Isolde ^a   Weyhenmeyer, Roland ^b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b Madaus AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; LACTATE DEHYDROGENASE; LIGNAN DERIVATIVE; PARACETAMOL; SILIBININ; SILICRISTIN; SILIDIANIN; SILYBUM MARIANUM EXTRACT; VINCRISTINE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VERO CELL;

ACETAMINOPHEN; ANIMALS; CELL DIVISION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CISPLATIN; DNA; KIDNEY; KIDNEY DISEASES; L-LACTATE DEHYDROGENASE; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTECTIVE AGENTS; PROTEIN BIOSYNTHESIS; SILYMARIN; VERO CELLS; VINCRISTINE;

EID: 0032797573     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Andres W (1996) Einfluß einiger Flavonoide und synthetischer Strukturanaloga auf die Proteinsynthese in isolierten Hepatozyten. Dissertation. Ludwig-Maximilians-Universität München, Fakultät für Medizin.
2. Baldew GS, Boymans AP, Mol JG and Vermeulen NP (1992) The influence of ebselen on the toxicity of cisplatin in LC-PK1 cells. Biochem Pharmacol 44:382-387.
3. Berenquer J and Carrasco D (1977) Münchner Med Wochenschr, p 119.
4. Bodenner DL, Dedon PC, Keng PC and Borch RF (1986) Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity. DNA cross-linking, and gamma-glutamyl transpeptidase inhibition. Cancer Res 46:2745-2750.
5. Bowmann LC, Houghton JA and Houghton PJ (1988) Formation and stability of vincristine-tubulin complex in kidney cytosols. Role of GTP and GTP hydrolysis. Biochem Pharmacol 37:1251-1257.
6. De Vita VT (1981) The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture. Cancer 47:1-13.
7. Dougherty RM (1962) Use of dimethyl sulphoxide for preservation of tissue culture cells by freezing. Nature (Lond) 193:550-552.
8. Dreller E (1988) Excretion of the urinary enzymes alanine aminopeptidase and beta-glucuronidase in cystostatic perfusion therapy. Zeitschrift für die Gesamte Innere Medizin and ihre Grenzgebiete 43:491-493.
9. Erlanger H and Cutler RE (1992) Cisplatin nephrotoxicity. Dialysis & Transplantation 21:559-566.
10. Feher J, Deak G, Muzes G, Lang I, Niederland V, Nekam K and Karteszi M (1989) Liver-protective action of silymarin therapy in chronic alcoholic liver diseases. Orvosi Hetilap 130:2723-2727.
11. Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W and Schneider B (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9:105-113.
12. Fintelmann V and Albert A (1980) Nachweis der therapeutischen Wirksamkeit von Legalon (Reg trademark) bei toxischen Lebererkrankungen im Doppelblindversuch. Therapiewoche 30:5589-5594.
13. Hahn G, Lehmann HD, Kürten M, Uebel H and Vogel G (1968) On the pharmacology and toxicology of silymarin, an antihepatotoxic active principle from Silybum marianum (L.) Gaertn. Arzneimittelforschung 18:698-704.
14. Jackson AM, Rose BD, Graff LG, Jacobs JB, Schwartz JH, Strauss GM, Yang JP, Rudnick MR, Elfenbein IB and Narins RG (1984) Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 101: 41-44.
15. Janiak B and Hänsel R (1960) Phytochemisch-pharmakognostische Untersuchungen über Fructus cardui mariae. Planta Med 8:71.
16. Koch H and Tscherny J (1983) Bioavailability of silymarin, 3: Splitting of silybin dihemisuccinate by plasma and liver esterases. Arch Pharm 316:426-430.
17. Lindl T and Bauer J (1989) Zell- und Gewebekultur 2. Auflage, Gustav Fischer Verlag, Stuttgart.
18. Machicao F and Sonnenbichler J (1977) Mechanism of the stimulation of RNA synthesis in rat liver nuclei by silybin. Hoppe Seyler's Z Physiol Chem 358:141-147.
19. Madias NE and Harrington JT (1978) Platinum nephrotoxicity. Am J Med 65:307-314.
20. McMurtry RJ, Snodgraas WR and Mitchell JR (1978) Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol Appl Pharmacol 46:87-100.
21. Meyer SL (1975) Data Analysis for Scientists and Engineers. John Wiley & Sons, Inc., New York.
22. Owellen RJ, Hartke CA, Dickerson RM and Hains FO (1976) Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Cancer Res 36:1499-1502.
23. 6), the first flavonolignan. Tetrahedron Lett 25:2911-2916.
24. Pouillart P (1993) Vincristine, in Handbook of Chemotherapy in Clinical Oncology (von Cvitkovic E, Droz JP, Armand JP and Khoury S eds) pp 309-311, Scientific Communication International Ltd., Channel Islands.
25. Prestayko AW, Crooke ST and Carter SK (1980) Cisplatin: Current Status and New Developments. Academic Press, Inc., New York.
26. Sharma UK, Jha V, Joshi K, Ahmed S and Sakhuja V (1995) A case of non-Hodgkin's lymphoma presenting with polyuria and acute renal insufficiency. Ren Fail 17: 165-169.
27. Sonnenbichler J, Goldberg M, Hane L, Madubunyi I, Vogl S and Zetl I (1986) Stimulatory effect of silibinin on the DNA synthesis in partially hepatectomized rat livers: Non-response in hepatoma and other malign cell lines. Biochem Pharmacol 35:538-541.
28. Sonnenbichler J, Machicao F, Mattersberger J and Rosen H (1981) Gesteigerte Leberzellregeneration unter dem Einluβ von Silymarin, in Der toxisch-metabolische Leberschaden, Hansisches Verlagskontor (Van De Ritis F, Csomos G and Braatz R eds), pp 28-36, Lübeck.
29. Sonnenbichler J, Mattersberger J and Rosen H (1976) Stimulation of RNA synthesis in rat liver and isolated hepatocytes by silybin, an antihepatotoxic agent from Silybum marianum L. Gaertn. Hoppe Seyler's Z Physiol Chem 357:1171-1180.
30. Sonnenbichler J and Zetl I (1984) Mechanism of action of silibinin. V. Effect of silibinin on the synthesis of ribosomal RNA, mRNA and tRNA in rat liver in vivo. Hoppe Seyler's Z Physiol Chem 365:555-566.
31. Sonnenbichler J and Zetl I (1986) Biochemical effects of the flavonolignan silibinin on RNA, protein and DNA synthesis in rat livers, in Progress in Clinical and Biological Research (Cody V, Middleton E and Karborne JB eds) vol 213, pp 319-331, Alan R. Liss, Inc., New York.
32. Sonnenbichler J and Zetl I (1988) Specific binding of a flavonolignan derivative to an estradiol receptor, in Progress in Clinical and Biological Research (Cody V, Middleton E, Karborne JB and Berck A eds) vol 280, pp 369-374, Alan R. Liss, Inc., New York.
33. Stevens J, Hayden P and Taylor G (1986) The role of glutathione conjugate metabolism and cysteine conjugate beta-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells. J Biol Chem 261:3225-3332.
34. Tay LK, Bregman CL, Masters BA and Williams PD (1988) Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res 48:, 2538-2543.
35. Wagner H, Hörhammer L and Münster R (1968) On the chemistry of silymarin (silybin), the active principle of the fruits from Silybum marianum (L.) Gaertn. (Carduus marianus L.). Arzneimittelforschung 18:688-696.
36. Wagner H, Seligmann O, Hörhammer L, Seitz M and Sonnenbichler J (1971) Zur Struktur von silychristin, einem zweiten silymarin-isomeren aus silybum marianum. Tetrahedron Lett 22:1895-1899.
37. Walker EM Jr and Gale GR (1981) Methods of reduction of cisplatin nephrotoxicity. Ann Clin Lab Sci 11:397-410.
38. Widholm JM (1972) The use of fluorescein diacetate and phenosafranine for determining viability of cultured plant cells. Stain Technol 47:189-194.
39. Zetl I (1985) Untersuchungen zur Beeinflussung der Nucleinsäuresynthesen in Leberzellen durch das Flavonolignan Silibinin. Dissertation. Ludwig-Maximilians-Universität München, Fakultät für Chemie und Pharmazie.